These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32489785)

  • 1. Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort.
    Atallah B; Khaddage R; Sadik ZG; Mallah SI; Lee-St John TJ; Alfardan S; Traina MI; Almahmeed W
    Glob Heart; 2020 Feb; 15(1):12. PubMed ID: 32489785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery.
    Zafrir B; Saliba W; Jaffe R; Sliman H; Flugelman MY; Sharoni E
    Eur J Prev Cardiol; 2019 Mar; 26(4):401-408. PubMed ID: 30426772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital.
    Palomäki A; Hällberg V; Ala-Korpela M; Kovanen PT; Malminiemi K
    Lipids Health Dis; 2016 Jul; 15(1):124. PubMed ID: 27460359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol.
    Khanderia U; Townsend KA; Eagle K; Prager R
    Chest; 2005 Feb; 127(2):455-63. PubMed ID: 15705982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid management in high risk coronary patients: how effective are we at secondary intervention?
    Zhu YY; Hayward PA; Hare DL; Stewart AG; Buxton BF
    Heart Lung Circ; 2012 Feb; 21(2):82-7. PubMed ID: 22153966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.
    Shah SJ; Waters DD; Barter P; Kastelein JJ; Shepherd J; Wenger NK; DeMicco DA; Breazna A; LaRosa JC
    J Am Coll Cardiol; 2008 May; 51(20):1938-43. PubMed ID: 18482661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of repeat lipid testing in patients with coronary heart disease.
    Virani SS; Woodard LD; Wang D; Chitwood SS; Landrum CR; Urech TH; Pietz K; Chen GJ; Hertz B; Murawsky J; Ballantyne CM; Petersen LA
    JAMA Intern Med; 2013 Aug; 173(15):1439-44. PubMed ID: 23817669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709).
    Kulik A; Abreu AM; Boronat V; Ruel M
    Contemp Clin Trials; 2017 Aug; 59():98-104. PubMed ID: 28611006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    J Am Coll Cardiol; 2019 Jun; 73(24):3210-3227. PubMed ID: 30423394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study.
    Waldeyer C; Seiffert M; Staebe N; Braetz J; Kohsiack R; Ojeda F; Schofer N; Karakas M; Zeller T; Sinning C; Schrage B; Westermann D; Sydow K; Blankenberg S; Brunner FJ; Schnabel RB
    Clin Ther; 2017 Nov; 39(11):2311-2320.e2. PubMed ID: 29103665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits?
    Kulik A; Ruel M
    Curr Opin Cardiol; 2011 Nov; 26(6):508-17. PubMed ID: 21934497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
    White CW; Gobel FL; Campeau L; Knatterud GL; Forman SA; Forrester JS; Geller NL; Herd JA; Hickey A; Hoogwerf BJ; Hunninghake DB; Rosenberg Y; Terrin ML;
    Circulation; 2001 Nov; 104(22):2660-5. PubMed ID: 11723015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting.
    Quin JA; Hattler B; Bishawi M; Baltz J; Gupta S; Collins JF; Grover FL; McDonald G; Shroyer AL
    J Am Coll Surg; 2013 Sep; 217(3):452-60. PubMed ID: 23891072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.